Literature DB >> 11804994

Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction.

E Douglas Lewandowski1, Raymond K Kudej, Lawrence T White, J Michael O'Donnell, Stephen F Vatner.   

Abstract

BACKGROUND: Reduced fatty acid oxidation in hypoperfused myocardium is believed to result from impaired oxidation in mitochondria. This study suggests another mechanism, that oxidative capacity exceeds regulated entry of long chain fatty acid (LCFA). The ability of myocardium to oxidize fatty acids and metabolize glucose during stenosis was examined in open chest, anesthetized pigs. METHODS AND
RESULTS: The left anterior descending (LAD) coronary artery was infused for 40 minutes (5 mL/min LAD) with [2-(13)C] butyrate (4 mmol/L), a short chain fatty acid (SCFA), plus [2-(13)C] glucose (10 mmol/L) in either nonischemic controls (n=4) or at the end of 5 hours of LAD flow reduction (40%, n=7). With LAD constriction, left ventricular wall thickening fell 45+/-8% (P<0.01). Despite glycolytic production of lactate and alanine, hypoperfused myocardium preferentially oxidized SCFA over endogenous LCFA. SCFA accounted for 63+/-4% (mean+/-SEM) of carbon units entering oxidation in both ischemic epicardium and endocardium versus only 38+/-4% and 40+/-6% in respective samples from normal myocardium (P<0.002). Unexpectedly, SCFA contributions were elevated in both endocardium and epicardium despite preserved epicardial blood flow versus a 58+/-9% drop in endocardial flow (P<0.05). No significant oxidation of glucose was evident, indicating that unlabeled fuels were primarily LCFA.
CONCLUSIONS: Because SCFA bypass LCFA transport into mitochondria, during LAD constriction, mitochondrial capacity to oxidize fatty acid exceeds LCFA entry for oxidation. Importantly, metabolic changes were disassociated from transmural tissue perfusion. These findings suggest that signals other than oxygen availability regulate fatty acid use during hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804994     DOI: 10.1161/hc0302.102594

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

Review 2.  Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow?

Authors:  E Douglas Lewandowski
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

3.  Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia.

Authors:  Raymond K Kudej; Mathew Fasano; Xin Zhao; Gary D Lopaschuk; Susan K Fischer; Dorothy E Vatner; Stephen F Vatner; E Douglas Lewandowski
Journal:  Cardiovasc Res       Date:  2011-08-11       Impact factor: 10.787

4.  Recruitment of NADH shuttling in pressure-overloaded and hypertrophic rat hearts.

Authors:  E Douglas Lewandowski; J Michael O'donnell; Thomas D Scholz; Natalia Sorokina; Peter M Buttrick
Journal:  Am J Physiol Cell Physiol       Date:  2007-01-17       Impact factor: 4.249

Review 5.  Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Authors:  Heinrich Taegtmeyer; Martin E Young; Gary D Lopaschuk; E Dale Abel; Henri Brunengraber; Victor Darley-Usmar; Christine Des Rosiers; Robert Gerszten; Jan F Glatz; Julian L Griffin; Robert J Gropler; Hermann-Georg Holzhuetter; Jorge R Kizer; E Douglas Lewandowski; Craig R Malloy; Stefan Neubauer; Linda R Peterson; Michael A Portman; Fabio A Recchia; Jennifer E Van Eyk; Thomas J Wang
Journal:  Circ Res       Date:  2016-03-24       Impact factor: 17.367

6.  Substrate dependence of the postischemic cardiomyocyte recovery: dissociation between functional, metabolic and injury markers.

Authors:  Cindy Tissier; David Vandroux; Lisa Devillard; Amandine Brochot; Daniel Moreau; Luc Rochette; Pierre Athias
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

7.  Expression of slow skeletal TnI in adult mouse hearts confers metabolic protection to ischemia.

Authors:  Kayla M Pound; Grace M Arteaga; Mathew Fasano; Tanganyika Wilder; Susan K Fischer; Chad M Warren; Adam R Wende; Mariam Farjah; E Dale Abel; R John Solaro; E Douglas Lewandowski
Journal:  J Mol Cell Cardiol       Date:  2011-05-26       Impact factor: 5.000

8.  Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.

Authors:  Marcello Panagia; Huamei He; Tomas Baka; David R Pimentel; Dominique Croteau; Markus M Bachschmid; James A Balschi; Wilson S Colucci; Ivan Luptak
Journal:  NMR Biomed       Date:  2020-02-17       Impact factor: 4.044

9.  Transmural distribution of metabolic abnormalities and glycolytic activity during dobutamine-induced demand ischemia.

Authors:  Mohammad N Jameel; Xiaohong Wang; Marcel H J Eijgelshoven; Abdul Mansoor; Jianyi Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-18       Impact factor: 4.733

Review 10.  Return to the fetal gene program protects the stressed heart: a strong hypothesis.

Authors:  Mitra Rajabi; Christos Kassiotis; Peter Razeghi; Heinrich Taegtmeyer
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.